care.coach Pilot for Bone Marrow Transplant

Brigham and Women's Hospital, Boston, MA
Bone Marrow TransplantCare.Coach - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if an avatar-based technology can improve outcomes for people admitted to the hospital for a transplant.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Antithymocyte globulin (ATG)
1
Rituximab
1
Participants with Sickle Cell Disease or β-Thalassemia

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: 3 weeks

1 day
Modification of care.coach
3 weeks
Patient Satisfaction Rate
Rate of Completion of the HCT Educational Modules
The Completion Rate Post-Pilot Survey
Baseline to 3 weeks
Patient Retention

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Antithymocyte globulin (ATG)
2
Rituximab
2
Participants with Sickle Cell Disease or β-Thalassemia

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

care.coach Pilot
1 of 1

Experimental Treatment

18 Total Participants · 1 Treatment Group

Primary Treatment: care.coach Pilot · No Placebo Group · N/A

care.coach Pilot
Behavioral
Experimental Group · 1 Intervention: Care.Coach · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 weeks

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,029 Previous Clinical Trials
755,798 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,272 Previous Clinical Trials
41,230,710 Total Patients Enrolled
Gregory Abel, MPH, MDPrincipal InvestigatorDana-Farber Cancer Institute

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be 18 years old or older.
Only certain healthcare professionals (such as DFCI/HCC HCT nurse navigators, inpatient HCT nurses, and HCT doctors and extenders) are allowed to participate in the study.
You have undergone a reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (HCT).
References

Frequently Asked Questions

Are there any open opportunities to enroll in this study?

"Affirmative. Clinicaltrials.gov's data implies that this research project, which was initially posted on November 1st 2022 is currently recruiting participants. 18 individuals need to be enrolled from two separate medical centres." - Anonymous Online Contributor

Unverified Answer

What is the participation rate of this experiment?

"Affirmative. According to the information published on clinicaltrials.gov, this medical trial is still actively enrolling patients as of November 21st 2022 - an edit from its initial posting date of November 1st. A total of 18 individuals will be accepted across 2 different sites." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top